Northern Trust Corporation Common Stock vs Revolution Medicines Inc. Common Stock — how do they compare? Northern Trust Corporation Common Stock trades at $162.48 (market cap $30.63B), while Revolution Medicines Inc. Common Stock trades at $190 (market cap $40.39B). The key difference: Revolution Medicines Inc. Common Stock is the larger of the two by market cap, and Northern Trust Corporation Common Stock pays a 1.96% dividend while Revolution Medicines Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Northern Trust Corporation Common Stock for 0 Days and Revolution Medicines Inc. Common Stock for 2 Days on average.
| NTRS | RVMD | |
|---|---|---|
Market Cap | $30.63B | $40.39B |
Volume | 964,550 | 2,941,009 |
Sector | Financials | Health |
52-Week High | $191.47 | $221.15 |
52-Week Low | $122.72 | $49.56 |
Typical Hold Time | 0 Days | 2 Days |
Enterprise Value | -$5.35B | $37.09B |
Dividend Yield | 1.96% | — |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Revolution Medicines (RVMD) trades at $188.44, down 2.84% on the day, amid a bearish technical signal. The company reported no revenue in 2025, with a net loss of $1.13 billion, and has missed earnings expectations for three consecutive quarters. However, recent positive developments include the start of a Phase 3 trial for RASONQUE in pancreatic cancer and FDA Breakthrough Therapy Designation, fueling analyst optimism.
The outlook balances high-risk, high-reward potential. Strong analyst support (91.67% buy ratings) and a $253.35 consensus price target suggest significant upside, driven by the promising oncology pipeline. Key risks include substantial cash burn, lack of current revenue, and clinical trial execution uncertainties, making the stock suitable for investors comfortable with biotech volatility.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Northern Trust Corporation is a financial holding company that provides asset servicing, asset management, wealth management, and banking services through its Asset Servicing and Wealth Management segments. It serves corporations, institutions, and affluent individuals across US and international markets.
Read more on NTRS →Revolution Medicines develops precision medicines for cancer. Its programs focus on targeting RAS-driven cancers and related signaling pathways.
Read more on RVMD →